Cargando…
Clinical Manifestations, Current and Future Therapy, and Long-Term Outcomes in Congenital Thrombotic Thrombocytopenic Purpura
Congenital thrombotic thrombocytopenic purpura (cTTP) is an extremely rare disease characterized by the severe deficiency of a disintegrin and metalloproteinase with thrombospondin type 1 motifs 13 (ADAMTS13), caused by ADAMTS13 mutations. While ADAMTS13 supplementation by fresh frozen plasma (FFP)...
Autores principales: | Sakai, Kazuya, Matsumoto, Masanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219024/ https://www.ncbi.nlm.nih.gov/pubmed/37240470 http://dx.doi.org/10.3390/jcm12103365 |
Ejemplares similares
-
No aggravation of congenital thrombotic thrombocytopenic purpura by mRNA-based vaccines against COVID-19: a Japanese registry survey
por: Hamada, Eriko, et al.
Publicado: (2022) -
Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023
por: Matsumoto, Masanori, et al.
Publicado: (2023) -
Long-term Kidney Outcomes in Patients With Acquired Thrombotic Thrombocytopenic Purpura
por: Little, Dustin J., et al.
Publicado: (2017) -
Immune thrombotic thrombocytopenic purpura: Spotlight on long-term outcomes and survivorship
por: Selvakumar, Sruthi, et al.
Publicado: (2023) -
Thrombotic thrombocytopenic purpura
por: Knöbl, Paul
Publicado: (2018)